Vivos Therapeutics annual debt-to-assets ratio
2019
2020
2021
2022
2023
2024
2025
Vivos Therapeutics Debt-to-Assets Ratio Growth & History (VVOS)
Vivos Therapeutics's debt-to-assets ratio was 0.54 for fiscal 2025.
View full Vivos Therapeutics company overviewVivos Therapeutics annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.54 | 0.36 | +202.53% |
| 2024 | 2024-12-31 | 0.18 | −0.12 | −40.41% |
| 2023 | 2023-12-31 | 0.30 | 0.12 | +69.30% |
| 2022 | 2022-12-31 | 0.18 | 0.12 | +199.55% |
| 2021 | 2021-12-31 | 0.06 | 0.01 | +15.27% |
| 2020 | 2020-12-31 | 0.05 | −0.44 | −89.63% |
| 2019 | 2019-12-31 | 0.49 | — | — |
Vivos Therapeutics quarterly debt-to-assets ratio
Q4.19
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.52 | 0.07 | +16.43% |
| Q1 2026 | 2026-03-31 | 0.49 | 0.37 | +295.05% |
| Q4 2025 | 2025-12-31 | 0.54 | 0.36 | +202.53% |
| Q3 2025 | 2025-09-30 | 0.49 | 0.30 | +163.09% |
| Q2 2025 | 2025-06-30 | 0.44 | 0.26 | +137.77% |
| Q1 2025 | 2025-03-31 | 0.12 | −0.04 | −22.22% |
| Q4 2024 | 2024-12-31 | 0.18 | −0.12 | −40.41% |
| Q3 2024 | 2024-09-30 | 0.19 | −0.14 | −42.15% |
| Q2 2024 | 2024-06-30 | 0.19 | −0.06 | −24.59% |
| Q1 2024 | 2024-03-31 | 0.16 | 0.02 | +17.77% |
| Q4 2023 | 2023-12-31 | 0.30 | 0.12 | +69.30% |
| Q3 2023 | 2023-09-30 | 0.32 | 0.17 | +106.97% |
| Q2 2023 | 2023-06-30 | 0.25 | 0.13 | +107.95% |
| Q1 2023 | 2023-03-31 | 0.14 | 0.06 | +81.30% |
| Q4 2022 | 2022-12-31 | 0.18 | 0.12 | +199.55% |
| Q3 2022 | 2022-09-30 | 0.15 | 0.12 | +401.76% |
| Q2 2022 | 2022-06-30 | 0.12 | 0.09 | +335.28% |
| Q1 2022 | 2022-03-31 | 0.07 | 0.02 | +29.59% |
| Q4 2021 | 2021-12-31 | 0.06 | 0.01 | +15.27% |
| Q3 2021 | 2021-09-30 | 0.03 | — | — |
| Q2 2021 | 2021-06-30 | 0.03 | — | — |
| Q1 2021 | 2021-03-31 | 0.06 | — | — |
| Q4 2020 | 2020-12-31 | 0.05 | −0.44 | −89.63% |
| Q4 2019 | 2019-12-31 | 0.49 | — | — |
Vivos Therapeutics debt-to-assets ratio trends
Over the last five fiscal years, Vivos Therapeutics's debt-to-assets ratio increased from 0.05 to 0.54, a change of 0.49. The latest reported quarter, Q2 2026, shows 0.52.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vivos Therapeutics source filings ↗